Baxter India gets CDSCO nod for Oxiris Filter to treat Covid-19 patients - (India Infoline via NewsPoints Desk)

  • Baxter India has received approval from the Central Drugs Standard Control Organization (CDSCO) to use its Oxiris filter set for the treatment of COVID-19 patients, as reported India Infoline on Wednesday.

  • The Oxiris blood purification filter is reportedly intended for use in critically ill COVID-19 patients requiring blood purification where excessive Inflammatory mediators are present.

  • The Oxiris set was previously used with the Prismaflex control unit for patients requiring blood purification including continuous renal replacement therapy and in conditions where excessive endotoxins and inflammatory mediators level exists.

  • The patient's blood passes through the Oxiris filter set, where it can absorb Inflammatory mediators and remove fluid, electrolytes and uremic toxins, before returning the patient's blood to the body, making it the only such filter set that does not necessitate the use of additional devices.

Did you like this article?